filgrastim-ayow

Generic: Releuko

300 mcg/0.5 mL, 480 mcg/0.8 mL — Prefilled Syringe

WHITE BLOOD CELL STIMULANTS

Also known as: RELEUKO

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 6 hours, 40 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
BCBS Federal Basic Option 2026
via Releuko
Tier 5 - Non-Preferred Specialty PA
BCBS Federal Standard Option 2026
via Releuko
Tier 5 - Non-Preferred Specialty PA
Source: CMS QHP JSON  ·  Formulary date: Mar 18, 2026  ·  Checked: 6 hours, 40 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
Longevity Health Plan (HMO I-SNP)
via Releuko
Tier 1 - Preferred Generic PA
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 6 hours, 40 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
NC State Health Plan - 80/20 Plus PPO 2026
via Releuko
Not Covered None
NC State Health Plan - 70/30 Standard PPO 2026
via Releuko
Not Covered None
NC State Health Plan - HDHP 2026
via Releuko
Not Covered None
Source: Excel (XLSX)  ·  Formulary date: Jan 5, 2026  ·  Checked: 6 hours, 40 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026 Tier 3 - Non-Formulary PA
Something not right?